Frulloni Luca

INSTITUTE

Azienda Ospedaliera Universitaria Integrata Verona

Email

luca.frulloni@univr.it

ADDRESS

Unità di Gastroeneterologia, Dipartimento di Medicina – p.le L. A. Scuro 10, Verona

PHONE

045 8124466

Developed skills and lines of research

Luca Frulloni earned his medical degree from the University of Perugia in 1987 and his PhD from the University of Padua in 1996. Since 2015, he has been a full professor and head of the Gastroenterology Unit at the Integrated University Hospital of Verona.

He conducts research in the field of pancreatic disorders, focusing on pathophysiology, clinical diagnosis, and therapeutic aspects at the Verona Pancreas Study Center. For the FFC Ricerca, he is studying intestinal organoids to evaluate and pharmacologically correct anomalies in fluid transport and anionic currents in patients with chronic pancreatitis.

He is the author of over 150 international publications, with more than 6,500 citations as of 2018.

Projects funded by FFC Ricerca as Principal Investigator or as Research Manager

FFC#5/2020
Intestinal organoids for assessment and pharmacological correction of abnormalities in fluid transport and anion currents in patients affected by pancreatitis

FFC#6/2018
Intestinal organoids for assessment and pharmacological correction of abnormalities in fluid transport and anion currents in patients affected by pancreatitis

Publications from FFC Research projects

Poerio N, Bugli F, Taus F et al. Liposomes loaded with bioactive lipids enhance antibacterial innate immunity irrespective of drug resistance. Sci Rep. 2017 Mar 27;7:45120. doi: 10.1038/srep45120.

Nisini R, Poerio N, Mariotti S, et al., The Multirole of Liposomes in Therapy and Prevention of Infectious Diseases. Front Immunol. 2018 Feb 5;9:155. doi: 10.3389/fimmu.2018.00155. eCollection 2018.

Noemi Poerio, Federica De Santis, Alice Rossi, Ana Henriquez, Federica Di Sano, Vincenzina Lucidi, Alessandra Bragonzi, Maurizio Fraziano. Preclinical study of a host-directed therapy based on Metformin and bioactive liposomes for the control of multidrug resistant P. aeruginosa infection. The Proceedings of the 16th Italian Convention of Investigators in Cystic Fibrosis. Multidisciplinary Respiratory Medicine, 2019, 14 (Suppl 1):5